Related Experiment Video
Updated: Feb 24, 2026
Assessing Functional Performance in the Mdx Mouse Model
Published on: March 27, 2014
Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy
Azeez Aranmolate1, Nathaniel Tse1, Holly Colognato2
1Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, 11794-8651, USA.
Background:
In Duchenne muscular dystrophy (DMD), the loss of the dystrophin component of the dystrophin-glycoprotein complex (DGC) compromises plasma membrane integrity in skeletal muscle, resulting in extensive muscle degeneration. In addition, many DMD patients exhibit brain deficits in which the cellular etiology remains poorly understood. We recently found that dystroglycan, a receptor component of the DGC that binds intracellularly to dystrophin, regulates the development of oligodendrocytes, the myelinating glial cells of the brain.
Results:
We investigated whether dystrophin contributes to oligodendroglial function and brain myelination. We found that oligodendrocytes express up to three dystrophin isoforms, in conjunction with classic DGC components, which are developmentally regulated during differentiation and in response to extracellular matrix engagement. We found that mdx mice, a model of DMD lacking expression of the largest dystrophin isoform, have delayed myelination and inappropriate oligodendrocyte progenitor proliferation in the cerebral cortex. When we prevented the expression of all oligodendroglial dystrophin isoforms in cultured oligodendrocytes using RNA interference, we found that later stages of oligodendrocyte maturation were significantly delayed, similar to mdx phenotypes in the developing brain.
Conclusions:
We find that dystrophin is expressed in oligodendrocytes and influences developmental myelination, which provides new insight into potential cellular contributors to brain dysfunction associated with DMD.
Insights
Duchenne muscular dystrophy (DMD) involves brain deficits. This study shows dystrophin in oligodendrocytes is crucial for brain myelination, offering new insights into DMD-related brain dysfunction.
Area of Science:
- Neuroscience
- Cell Biology
- Genetics
Background:
- Duchenne muscular dystrophy (DMD) is characterized by skeletal muscle degeneration due to dystrophin loss.
- Brain deficits are common in DMD patients, but their cellular causes are unclear.
- Dystroglycan, a dystrophin-binding protein, is known to regulate oligodendrocyte development.
Purpose of the Study:
- To investigate the role of dystrophin in oligodendrocyte function and brain myelination.
- To determine if dystrophin isoforms are expressed in oligodendrocytes and their regulation.
Main Methods:
- Studied dystrophin isoform expression in oligodendrocytes during differentiation.
- Utilized mdx mice, a model for DMD, to assess myelination and oligodendrocyte progenitor proliferation.
- Employed RNA interference in cultured oligodendrocytes to block dystrophin expression.
Main Results:
- Oligodendrocytes express multiple dystrophin isoforms, developmentally regulated with differentiation.
- Mdx mice exhibit delayed brain myelination and aberrant oligodendrocyte progenitor proliferation.
- Inhibition of oligodendroglial dystrophin isoforms in vitro significantly delayed oligodendrocyte maturation.
Conclusions:
- Dystrophin is expressed in oligodendrocytes and plays a vital role in developmental myelination.
- This finding provides a cellular basis for understanding brain dysfunction in Duchenne muscular dystrophy.
